We design creams with the culture of active ingredient release in medicine.
You will have a new collection very soon.
The new skin care collection that we are about to make available to you brings three major innovations.
And the greatest of them all is a galenic designed so that the active ingredients reach the last frontier of what can be considered a cosmetic: the basal membrane and the papillary dermis.
Beyond that point, we would be talking about a drug.
It is right there where the cells are that will make the difference in the most difficult thing to recover: the firmness of the skin.
New technologies for even better results.
As in medicine, getting active ingredients to where they need to perform their biological function is a major challenge. In the new collection, we push the state of the art in topical delivery of active ingredients.
More details about...
Our R&D in oncology
Our proposed therapy is based on the use of a recombinant protein that stimulates the production of a specific leukocyte.
The treatment is currently in advanced stages of clinical trials. We conducted this research with the BCCC of the Hospital Clínic de Barcelona.
Our hope is that the treatment we have been working on for 15 years will help reduce metastatic lesions in patients.
Please contact us if you have any questions.
We can tell you more about how long it will be before you see the new products.
endor@endortechnologies.com
t: 634 544 026